Wedbush Securities has a solid track record with many publicly traded companies it covers. Over the past few months, the investment firm hiked its price target on several intriguing companies, many of which may prove great buys after the recent wave of market volatility. Of course, investors shouldn’t treat any analyst rating and price targets
Healthcare stocks certainly haven’t set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500. Yet, many leading healthcare companies just issued better-than-expected financial results for this year’s first quarter. Additionally, these stocks tend to perform well during
Here are three prominent Dow stocks facing challenges that every investor should be aware of. Even with any business’s challenges, savvy investors can identify possible openings for strategic positioning. The first company, a mainstay in the aerospace sector, is grappling with cash flow issues and an uncertain future. However, amidst these challenges, there are opportunities
Not everyone is feeling good about the stock market. Inflation has been picking up, and interest rates have remained elevated. Earnings reports for tech companies have been good for the most part, but that doesn’t mean the market will remain attractive over the next few years. Time in the market beats timing the market. However, some corporations
The Dow Jones Industrial Average has been around since 1885. The index contains 30 stocks and has regularly added and removed holdings from the list. An index with 30 stocks has more concentration than indices like the S&P 500 and the Nasdaq 100, which spread their assets across more holdings. However, some Dow stocks to buy are better than others. Investors must
Tech stock investors have seen tremendous volatility over the past few years. While many stocks have soared, not al have. Thus, it is always a good idea to keep in mind which companies are worth adding to, and which are tech stocks to sell. If you look at broader indexes, that may not seem true. However, if you exclude the
We’re a little more than halfway through first-quarter earnings season, so now is the time to review this earnings season winners and losers. In general, market results have been encouraging so far. Forty-six percent of companies listed on the S&P 500 have reported their quarterly results. Seventy-seven percent beat forecasts with their earnings or profits,
Biotech stocks are full of intriguing innovators who could help pave the way for greater gains over the years ahead. Undoubtedly, it’s virtually impossible to tell exactly which pills, shots and treatments within a firm’s pipeline will eventually evolve into cash flows, let alone blockbuster cash cows. With many clinical trials to pass, even a
Not every stock crashes with the rest of the market. Some corporations offer high margins of safety and can hold firmly during bad times. Putting some of your capital in these investments can reduce your portfolio’s losses from peak to trough. However, a small number of stocks can actually perform well when the market crashes. It’s harder to find
The U.S. economy is slowing, which is bad news for consumer stocks. In recent days, economic data showed that gross domestic product (GDP) in America grew at an annualized rate of 1.6% in the year’s first quarter, considerably slower than the preceding quarter’s 3.4% growth. At the same time, the personal consumption expenditures (PCE) price
While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of recessions that Western economies experienced over the last 40 years or so. These downturns, however, provide opportunities for investors to buy stocks at
Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks. Each exhibits unique approaches and accomplishments in biotechnology, healthcare services, and pharmaceuticals. Solid product leads, especially in the U.S. market, have propelled the first company’s biosimilar industry to an astounding rise.
If you’ve been paying attention to the market, a bearish list on oil and gas stocks might seem odd. Looking at two primary indicators of crude prices — West Texas Intermediate (WTI) and Brent crude oil — prices for the commodity have risen steadily in 2024. For some perspective, the WTI has risen 17% on
In this article MSFT Follow your favorite stocksCREATE FREE ACCOUNT Microsoft Chief Executive Officer (CEO) Satya Narayana Nadella speaks at a live Microsoft event in the Manhattan borough of New York City, October 26, 2016. Lucas Jackson | Reuters Microsoft has signed a deal with Brookfield Asset Management to invest more than $10 billion to
Alphabet’s (NASDAQ:GOOG, NASDAQ:GOOGL) Gemini AI has once again been overtaken by other models, but it remains one of the best choices out there for AI stock predictions. Bard (the company’s model preceding Gemini) was previously ranked by analysts as the best AI tool for stock picking, even outperforming human stock pickers a test run. However, Gemini has
It’s not all fun and games when it comes to the market’s top spatial computing (or metaverse) stocks. Undoubtedly, we’ve seen some pretty capable mixed-reality headsets launching in recent years. And with the launch of Apple (NASDAQ:AAPL) Vision Pro, it seems like mixed reality isn’t all too far off from making its mark on the
When the going gets tough, the tough buy blue chip stocks. That’s because they are safe havens in times of turmoil. These are large companies with a proven track record of success and profits that have sterling financial statements. That means when markets go south, they will continue standing tall. The following three blue chip
The average investor probably appreciates no-hassle investments more than anything else. Most investors simply want to set it and forget it when it comes to their portfolio. Far fewer investors are willing or capable of spending their time tethered to trading stations in an attempt to find Alpha. That’s part of the reason blue-chip stocks
Once mainly a develop of operating systems for desktop computers, Microsoft (NASDAQ:MSFT) is mainly a cloud-computing and artificial intelligence technology company now. Yet, even Microsoft has its weak points, and Microsoft stock gets a “B” grade and investors may choose to hold their current share position. Adding some Microsoft shares to your portfolio is fine, but
As is always the case, earnings season is a mixed bag. Companies that surprise on the upside and issue bullish guidance are seeing their share price rise 10% or more in a day. Companies that miss forecasts and offer a downbeat outlook are seeing their stock slide 10% lower or more in a single trading